Search Results - "Petitjean, Hélène"

Special Issue on ischemic heart disease by Lancellotti, Patrizio, Petitjean, Hélène, Nchimi, Alain, Cosyns, Bernard

Get full text

Focus on valvular heart disease by Lancellotti, Patrizio, Petitjean, Hélène, Postolache, Adriana, Cosyns, Bernard

Get full text

Focus issue on cardiomyopathies by Lancellotti, Patrizio, Petitjean, Hélène, de Marneffe, Nils, Cosyns, Bernard

Get full text

Leading trends in pacemaker implantation after aortic valve replacement in Italy by Lempereur, Mathieu, Nguyen-Trung, Mai-Linh, Petitjean, Hélène, Lancellotti, Patrizio

Get full text

The burden and challenges of managing aortic stenosis by Reskovic Luksic, Vlatka, Separovic Hanzevacki, Jadranka, Trung, Mai-Linh Nguyen, Petitjean, Hélène, Lancellotti, Patrizio

Get full text

Secondary prevention of cardiovascular diseases : targeting all the cardiovascular risk factors by Moonen, Marie, Petitjean, Hélène, Lancellotti, Patrizio

“…This article focuses on the secondary prevention of cardiovascular (CV) diseases, namely the prevention of recurrence in subjects with a personal history of CV…”
Get more information

A new integrative approach combining right heart catheterization and echocardiography to stage aortic stenosis-related cardiac damage by Viva, Tommaso, Postolache, Adriana, Nguyen Trung, Mai-Linh, Danthine, Pauline, Petitjean, Hélène, Bruno, Vito Domenico, Martinez, Christophe, Lempereur, Mathieu, Guazzi, Marco, Aghezzaf, Samy, Coisne, Augustin, Oury, Cécile, Dulgheru, Raluca, Lancellotti, Patrizio

“…Although staging of the extent of aortic stenosis (AS)-related cardiac damages is usually performed via echocardiography, this technique has considerable…”
Get full text

Cardiac Damage and Conduction Disorders after Transcatheter Aortic Valve Implantation by Damas, François, Nguyen Trung, Mai-Linh, Postolache, Adriana, Petitjean, Hélène, Lempereur, Mathieu, Viva, Tommaso, Oury, Cécile, Dulgheru, Raluca, Lancellotti, Patrizio

“…Recently, a staging system using 4 grades has been proposed to quantify the extent of cardiac damage associated with aortic stenosis (AS), namely AS-related…”
Get full text

Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non–ST-segment elevation myocardial infarction: The TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial by Chin, Chee Tang, MBChB, Roe, Matthew T., MD, MHS, Fox, Keith A.A., MBChB, Prabhakaran, Dorairaj, MD, Marshall, Debra A., MD, Petitjean, Helene, MD, Lokhnygina, Yuliya, PhD, Brown, Eileen, PhD, Armstrong, Paul W., MD, White, Harvey D., MD, Ohman, E. Magnus, MD

“…Practice guidelines recommend dual antiplatelet therapy with aspirin and clopidogrel for patients with non–ST-segment elevation acute coronary syndromes (NSTE…”
Get full text

Aortic stenosis : new developments in management by Hanoul, Chloé, de Marneffe, Nils, Dulgheru, Raluca Elena, Damas, François, Tajildin, Riad, Petitjean, Hélène, Lancellotti, Patrizio

“…Aortic stenosis (AS) is the most common valve disease in our countries; most often of degenerative origin, its prevalence is constantly increasing due to the…”
Get more information

Cardio-oncology and cardio-obstetrics : crucial role of a multidisciplinary approach by Petitjean, Hélène, de Marneffe, Nils, Nguyen-Trung, Mai-Linh, Hanoul, Chloé, Rorive, Andrée, Moonen, Marie, Lancellotti, Patrizio

“…In this clinical case, we describe the cardio-oncological history and the complexity of the management of a patient presenting a breast cancer diasgnosed…”
Get more information

Advances in pulmonary hypertension diagnosis and risk stratification by Maloir, Quentin, Petitjean, Hélène, Parzibut, Gilles, Weber, Thierry, Davidsen, Cedric, Dulgheru, Elena, Lancellotti, Patrizio, Louis, Renaud, Guiot, Julien, Humbert, Marc

“…Pulmonary hypertension (PH) is a common clinical condition linked to chronic cardiopulmonary illnesses. It must be distinguished from pulmonary arterial…”
Get more information

Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study by Montalescot, Gilles, Sideris, Georgios, Cohen, Remy, Meuleman, Catherine, Bal dit Sollier, Claire, Barthélémy, Olivier, Henry, Patrick, Lim, Pascal, Beygui, Farzin, Collet, Jean-Philippe, Marshall, Debra, Luo, Junxiang, Petitjean, Helene, Drouet, Ludovic

“…Compared with the approved dose regimen of clopidogrel (300-mg loading dose [LD], 75-mg maintenance dose [MD]), prasugrel has been demonstrated to reduce…”
Get more information